A systemic type i 5 α-reductase inhibitor is ineffective in the treatment of acne vulgaris
- 1 March 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 50 (3) , 443-447
- https://doi.org/10.1016/j.jaad.2003.07.021
Abstract
No abstract availableKeywords
Funding Information
- Merck
This publication has 14 references indexed in Scilit:
- MK-386, an Inhibitor of 5 -Reductase Type 1, Reduces Dihydrotestosterone Concentrations in Serum and Sebum without Affecting Dihydrotestosterone Concentrations in SemenJournal of Clinical Endocrinology & Metabolism, 1997
- Activity of the Type 1 5α-Reductase Exhibits Regional Differences in Isolated Sebaceous Glands and Whole SkinJournal of Investigative Dermatology, 1995
- Acne Vulgaris in Premenarchal GirlsArchives of Dermatology, 1994
- Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.Journal of Clinical Investigation, 1993
- Cyproterone Acetate Versus Levonorgestrel Combined with Ethinyl Estradiol in the Treatment of Acne: Results of a multicenter study*Acta Obstetricia et Gynecologica Scandinavica, 1986
- Is the metabolism of testosterone to 5α-dihydrotestosterone required for androgen action in the skin?British Journal of Dermatology, 1982
- Activity of Testosterone 5α-Reductase in Various Tissues of Human SkinJournal of Investigative Dermatology, 1980
- Endocrinologic Control to the Development and Activity of the Human Sebaceous GlandJournal of Investigative Dermatology, 1974
- THE HORMONAL CONTROL OF HUMAN SEBACEOUS GLANDSPublished by Elsevier ,1963
- Sebum Secretion and Urinary Fractional 17-Ketosteroid and Total 17-Hydroxycorticoid Excretion in Male Castrates**From the Department of Dermatology, Boston University School of Medicine, and Evans Memorial of Massachusetts Memorial Hospitals, Boston 18, Massachusetts.Journal of Investigative Dermatology, 1962